Skip to main content

Prediction of Clinical Response to 5-Fluorouracil-Containing Chemotherapy: Preliminary Results of in Vitro Assay in Human Breast Cancer

  • Chapter
Cancer Chemo- and Immunopharmacology

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 74))

Summary

An in vitro assay system measuring the production of phosphorylated nucleotide products of 5-FU by human tumor cytosols is described. Samples from 11 patients with breast cancer treated with 5-FU-containing chemotherapy regimens were assayed. Significant differences were seen in quantitative and qualitative patterns of phosphorylation between samples from chemotherapy responding and nonresponding patients. The rate of 5-fluorodeoxyuridylate production and the amount of nucleotide triphosphate produced were significantly P < 0.05 increased in chemotherapy-re- sponding patients. This in vitro assay system is a simple, reproducible procedure that requires further evaluation as a potential system for prospectively predicting clinical response to fluorinated pyrimidines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ardalan B, Macdonald JS, Cooney D, Schein PS (1979) Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors. Bull Cancer 66:55–59

    PubMed  CAS  Google Scholar 

  2. Canellos GP, DeVita VT, Gold GL, Chabner BA, Schein PS, Young RC (1976) Combination chemotherapy for advanced breast cancer: Response and effect on survival. Ann Intern Med 84:389–392

    PubMed  CAS  Google Scholar 

  3. Duschnisky R, Pleven E (1957) The synthesis of 5-fluoro-pyrimidines. J Am Chem Soc 79:4559–4560

    Article  Google Scholar 

  4. Friedman MA, Sadee W (1978) The fluoropyrimidines: Biochemical mechanisms and design of clinical trials. Cancer Chemother Pharmacol 1:77–82

    Article  PubMed  CAS  Google Scholar 

  5. Heidelberger C (1965) Fluorinated pyrimidines. Prog Nucleic Acid Res Mol Biol 4:1–50

    Article  PubMed  CAS  Google Scholar 

  6. Heidelberger C, Chaudhuri NK, Pleven E, Scheiner J (1957) Fluorinated pyrimidines, a new class of tumor-inhibiting compounds. Nature 179:663–666

    Article  PubMed  CAS  Google Scholar 

  7. Heidelberger C, Greisbach L, Montag BJ, Mooren D, Cruz O, Schneizer RJ, Grunberg E (1958) Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Res 18:305–317

    PubMed  CAS  Google Scholar 

  8. Livingston RB, Carter SK (1970) Single agents in cancer chemotherapy. Plenum, New York

    Google Scholar 

  9. Roberts D (1966) An isotopic assay for thymidylate synthetase. Biochemistry 5:3546–3548

    Article  PubMed  CAS  Google Scholar 

  10. Sawyer R, Nayak R, Spiegelman S, Martin D (1979) Mechanism of action of 5-fluorouracil (FU) in the chemotherapy of the murine mammary tumor. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:263

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ardalan, B., Macdonald, J., Cooney, D., Lippman, M., Schein, P. (1980). Prediction of Clinical Response to 5-Fluorouracil-Containing Chemotherapy: Preliminary Results of in Vitro Assay in Human Breast Cancer. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81488-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81488-4_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81490-7

  • Online ISBN: 978-3-642-81488-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics